Prevalence of the UGT1A1*6 (c.211G>A) polymorphism and irinotecan toxicity in Iranian populations of different ethnicities
Background: Pharmacogenetic studies on irinotecan treatment in patients with metastatic colorectal cancer have indicated that genetic polymorphisms in UGT1A1*6 can lead to decreased enzyme activity and accumulation of the toxic metabolite SN-38. Here, we compared the prevalence of UGT1A1*6 in an Ira...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2015
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/45994/1/Prevalence%20of%20the%20UGT1A16%20%28c.211GA%29%20polymorphism%20and%20irinotecan%20toxicity%20in%20Iranian%20populations%20of%20different%20ethnicities.pdf |